News & Insights

SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its second quarter 2024 financial results on Thursday, August 8, 2024, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a second quarter 202

IRVINE, Calif.--(BUSINESS WIRE)-- #ClinicalTrials--Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and disease-related immune dysfunction, announced today its partnership with Springbok Analytics, a life sciences muscle analytics company. Springbok is building a new standard in muscle health with its MRI-based AI muscle analysis technology that is used widely throughout elite sports, human performance and life sciences. Immunis is using Springbok’s technology to e

LOS ANGELES--(BUSINESS WIRE)-- #biomarkers--According to a comprehensive market report authored by DeciBio Consulting LLC, “Oncology Liquid Biopsy (LBx) Market Report 2024 – 2029,” the global oncology liquid biopsy market is predicted to reach $10.1B by 2029, driven by a broad push for increased biomarker testing globally, updated testing guidelines, and expansion in coverage for testing. This third-edition of DeciBio’s liquid biopsy report takes an updated and comprehensive look at the LBx landscape. Inform

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus CEO, Shawn O'Connor, will be presenting at KeyBanc's 25th Annual Technology Leadership Forum in Vail, CO, on Monday, August 5, 2024.

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth. Edwards has entered into an agreement to acquire JenaValve Technology, a pioneer in the transcatheter treatment of aortic regurgitation (AR), a deadly disease that impacts a significant and growing population and is la

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2024. Highlights and Outlook Q2 sales grew 7%; constant currency1 sales grew 8% Q2 TAVR sales grew 5%; constant currency1 sales grew 6% Q2 TMTT sales grew 75%; increasing contribution to Edwards' growth Q2 EPS of $0.61; adjusted1 EPS of $0.70 Significant TAVR and TMTT clinical evidence to be presented at TCT in October 2024 Positive EVOQUE introduction with excellent

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”) (OTCQX: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the second quarter 2024 after the market close on Wednesday, August 7th, 2024. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results. Investors interested in listening to the conference call may do so by d

IRVINE, Calif.--(BUSINESS WIRE)-- #agilon--Biogennix, an osteobiologics company specializing in innovative healing solutions for surgical procedures, has announced the launch of its new Agilon Surgical Matrix wound care product. Agilon Surgical Matrix is a wound care solution derived from 100% bovine Type 1 collagen. Upon contact with a new or open wound, whether surgically or naturally occurring, Agilon Surgical Matrix transforms into a gel, enveloping the entire wound area. This coverage maintains a lo

LOS ANGELES--(BUSINESS WIRE)--Pearl Raises Largest-Ever Investment in Dental AI with $58 Million Round

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release second quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, August 6, 2024. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Micah Young, Executive Vice President and Chief Financial Officer. To register for the conference call and receive the dial-in number, please use

LOS ANGELES--(BUSINESS WIRE)-- #aisalivatracker--OVUL, is excited to announce the launch of its revolutionary saliva-based AI-fertility tracker on August 1st, 2024 - a groundbreaking tool designed to help women accurately monitor their ovulation cycles with ease and precision. This innovative device combines the simplicity of a three-step process with advanced AI technology, turning daily health tracking into a quick and enjoyable moment. At OVUL, we're committed to sustainability. The device is not only effectiv

PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on August 8, 2024, at 4:30 p.m. ET to discuss its financial results for the fiscal third quarter ended June 30, 2024. Webcast and Conference Call and Details Investors may access a live audio webcast on the Company's website at http://ir.arrowheadpharma.com/events.cfm. A replay of the webcast will be available approximately two hours after the conclus

IRVINE, Calif.--(BUSINESS WIRE)-- #IntegratedEndoscopy--Integrated Endoscopy, a medical device company pioneering the development of the wireless arthroscopic surgery market, has announced the commercial launch of its advanced Nuvis Wireless Camera System. The Nuvis wireless camera system offers surgeons and health centers next-generation wireless communication at a cost below traditional corded cameras. The proprietary channel hopping technology ensures latency-free, secure and highly reliable connectivity. Also, th

OXFORD, England, & LOS ANGELES--(BUSINESS WIRE)-- #Nanopore--Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, and Plasmidsaurus, the LA-based company that introduced overnight whole-plasmid sequencing, today announced an expanded, multi-year contract and a collaboration aimed at transforming the plasmid sequencing market through the application of nanopore technology. Plasmidsaurus has pioneered a rapid, whole-plasmid sequencing service b

COLORADO SPRINGS, Colo. & ALISO VIEJO, Calif.--(BUSINESS WIRE)-- #SNIS2024--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced the recently published results of the CLinical EValuation of WEB 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms. The CLEVER study was a multicenter, prospective study evaluating the WEB 17 system in ruptured and unruptured aneurysms to understand th

IRVINE, Calif.--(BUSINESS WIRE)--Hyperice announces the availability of its Hyperice X line in Canada.

LOS ANGELES--(BUSINESS WIRE)---- $CDXC #CellularHealth--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, launches the Niagen+ NAD+ Test Kit*, now available exclusively through the company’s healthcare practitioner (HCP) channel. This innovative test kit provides practitioners with a reliable method for measuring patient blood NAD+ levels, helping them create more personalized and effective patient protocols using ChromaDex’s NAD+-boos

IRVINE, Calif.--(BUSINESS WIRE)--Assistance Now, a provider of safety wear for seniors and disabled persons, is releasing The Mobli, a safety smartwatch that monitors safety and well-being. Loved ones can easily view vitals, daily activity, medications taken, location and an easy push to talk feature with no need to fuss with buttons or software on the watch. The Mobli includes a proprietary software called “FallSoft” which helps predict falls using AI and advanced algorithms. Samsung’s state-o

LOS ANGELES--(BUSINESS WIRE)--On Aug. 1, Puma Biotechnology will issue its earnings results for the 2024 second quarter and follow with a conference call to discuss the results.

LONG BEACH, Calif.--(BUSINESS WIRE)-- #biotech--California Manufacturing Technology Consulting® (CMTC) recently provided strategic planning and marketing assistance to San Diego biotech manufacturer Instant Biologics to help the company grow their business. Founded in 2018, Instant Biologics manufactures effervescent tablets that transform chemical and biological water-based products into compact, lightweight, waterless concentrates, helping to minimize cost, carbon footprint, and waste across the entire

LOS ANGELES--(BUSINESS WIRE)--Pearl, the global leader in dental AI solutions, and Patterson Dental Canada, Inc., a subsidiary of Patterson Companies, Inc. (Nasdaq: PDCO), today announced a collaboration to expand access to Pearl’s Second Opinion® AI disease detection capabilities within the Canadian dental market. Pearl’s real-time pathology detection AI software, Second Opinion®, assists dentists in their radiologic evaluation and case presentation of dental conditions commonly found in denta

SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS (NYSE: FIGS), the leading global medical apparel brand, today announced the launch of its largest campaign to date, celebrating the Team USA Medical Team at the Olympic and Paralympic Games Paris 2024. FIGS is the first brand to outfit the over 250 healthcare professionals supporting Team USA athletes, marking a historic milestone in the world of healthcare and sports. “Our mission at FIGS is to celebrate, empower and serve those who serve others,” sa

THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of its Biologics License Application (BLA) for tabelecleucel (tab-cel®) indicated as monotherapy for treatment of adult and pediatric

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2024 after the market closes on Wednesday, July 24, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at ir.edwards.com. About Edwards Li

ALISO VIEJO, Calif.--(BUSINESS WIRE)-- #microvention--MicroVention, a fully owned subsidiary of Terumo Corporation, announced today that the United States District Court for the Central District of California has issued an injunction permanently enjoining defendants David Ferrera, Nguyen (“Jake”) Le and Michelle Tran, former employees of MicroVention (“defendants”), from using, disclosing, or possessing any MicroVention trade secret information or confidential information and requiring that they undergo certai

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that it has commenced litigation against Politan Capital Management LP (“Politan”) in federal court in California seeking to require Politan to correct material misstatements and omissions in Politan’s proxy materials. The complaint alleges, among other things, that Quentin Koffey has assisted plaintiff’s couns

IRVINE, Calif.--(BUSINESS WIRE)--To ensure that Politan lies repeated over and over are not taken as fact, Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) sets forth below facts in response to what we believe are some of Politan’s and Quentin Koffey’s most egregious and continuing misrepresentations. These misrepresentations include Politan’s and Mr. Koffey’s continuing efforts to sow mistrust and confusion regarding the proposed consumer joint venture. In response, Masimo CEO Joe

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an early-stage transcatheter mitral valve replacement (TMVR) company, following its initial investment in 2017. Since that time, Innovalve has demonstrated progress in its program with promising early clinical experience. Combined with Edwards’ existing mitral innovations, the acquisition enhances the company’s TMVR technologies to address large unm

EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its second quarter 2024 financial results before the market opens on Friday, August 2, 2024. Management will host a conference call for the investment community the same day at 8:30 AM ET (5:30 AM PT) to discuss the results and answer ques

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) today highlighted the actions taken by Politan and Quentin Koffey since Masimo’s 2023 Annual Meeting of Stockholders that directly contradict their purported commitment to good governance. Over the past twelve months, we believe Politan’s Quentin Koffey has repeatedly acted against the best interests of Masimo and its stockholders. The summary provided below shows stockholders and the public the numer

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus was selected for a new project with the International Collaboration on Cosmetics Safety to advance animal-free safety assessments.

VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical announces positive topline results from landmark RESET-RA study for the treatment of rheumatoid arthritis

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release second quarter 2024 financial results after the market close on Wednesday, July 31, 2024. The company’s management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PT (4:30 p.m. ET) on July 31, 2024. A link to the

ALISO VIEJO, Calif.--(BUSINESS WIRE)-- #microvention--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced the publication of the SOFIA™ Aspiration System as first-line Technique (SOFAST): A prospective, multicenter study to assess the efficacy and safety of the 6 French SOFIA™ Flow Plus Aspiration Catheter for endovascular stroke thrombectomy, recently published in the Journal of NeuroInterventional Surgery (JNIS). The SOFAST study assessed the SOFIA™

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Roth Capital Partners Announces the Addition of Benjamin E. Paluch, Ph.D. and Boobalan Pachaiyappan, Ph.D. to its Healthcare Research Team

THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported the grant of 2,200 restricted stock units of Atara’s common stock to one newly hired employee. This award was approved by the Compensation Committee of Atara’s Board of Directors and granted under the Atara

THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal Touchon, President and Chief Executive Officer, will participate in a fireside chat at the Stifel Virtual Cell Therapy Forum on Tuesday, July 9, 2024 at 6:45 a.m. PDT / 9:45 a.m. EDT. A live web

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology granted an inducement award to one new employee, who was hired in June 2024.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today reported 3QFY24 total revenue of $18.5 million, up 14% over 3QFY23, and 9 months FY24 total revenue of $51.3 million, up 17%.

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) today issued the following statement to address what Masimo strongly believes is Politan’s campaign of deception and distraction to deflect attention from its own failures and its nominees’ shortcomings. The Company urges investors to choose Masimo’s commitment to transparency and value creation over what it believes are Politan’s fabrications and deflections by voting FOR Masimo nominees Joe Kiani an

SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- #CLIFighters--Reflow Medical, Inc., a developer of innovative devices focused on cardiovascular disease, announces the first patient enrollments in “A pilot study of the Drug-Eluting Coronary Spur™ StEnt as a Primary trEatment for in-stent Restenosis (ISR) of the CORONARY arteries” (DEEPER CORONARY, NCT06117150). ISR is a common clinical problem that can generate significant health care costs and is often associated with an increased risk of death and rehospitalization.

VALENCIA, Calif.--(BUSINESS WIRE)-- #cochlearimplant--Advanced Bionics (AB), a global leader in cochlear implant technology, is pleased to announce the appointment of Alistair Simpson as its new president, and Group Vice President (GVP) for cochlear implants on the Sonova Management Board, effective immediately. Vicky Carr-Brendel, Ph.D., has decided to retire from executive roles as GVP Cochlear Implants and President of Advanced Bionics for personal reasons at the end of June, 2024, after successfully leading t

LOS ANGELES--(BUSINESS WIRE)---- $CDXC #ChromaDex--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, today announced its inclusion in the Russell 2000® Index as part of the annual reconstitution of the Russell stock indexes. This inclusion will be effective at the opening of U.S. equity markets on Monday, July 1, 2024, based on the preliminary list of additions posted on Friday, May 24, 2024. Rob Fried, CEO of ChromaDex and Founde

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) today issued a letter to stockholders in connection with the Company’s 2024 Annual Meeting of Stockholders. The letter highlights the fierce independence and deep medtech experience of nominee Christopher Chavez and contrasts it to Politan’s handpicked and paid nominees. Masimo believes that ceding control of Masimo to Politan by electing its nominees would jeopardize the value of your investment in M

IRVINE, Calif.--(BUSINESS WIRE)--The Masimo W1® Sport advanced health tracking wearable is gaining a powerful new feature, scientifically based sleep analysis with Sleep Halo™.

PASADENA, Calif. & BERKELEY, Calif.--(BUSINESS WIRE)--Freeflow Ventures, an early stage venture capital firm that invests in science-driven solutions to human and planetary health challenges, announced today that it raised $50M in new funds through its $35M Fund Two and $15M Opportunity Fund. Including a $25M Fund One and $15M in SPVs, Freeflow now has $90M in assets under management. In a challenging market for venture capital, Freeflow doubled its fundraising from the Fund One to Fund Two cyc

IRVINE, Calif.--(BUSINESS WIRE)-- #ClinicalTrials--Immunis, Inc., a private biotechnology company developing regenerative secretomes for age and disease-related immune dysfunction, is delighted to welcome Dr. Christina Weng as its newest Advisory Board member. Dr. Weng is an accomplished physician-scientist, entrepreneur, and biotech executive. She is a board-certified dermatologist at the Massachusetts General Hospital and faculty at Harvard Medical School. An expert in regenerative medicine, she currently serv

IRVINE, Calif. & CLEVELAND--(BUSINESS WIRE)--Masimo and Cleveland Clinic are launching a new partnership centered around hospital-based remote patient monitoring, including TeleCritical Care.

LOS ANGELES--(BUSINESS WIRE)-- #calderamedical--Caldera Medical, a global leader in women’s pelvic health, is proud to announce its sponsorship of the Cynisca Cycling team. This partnership reflects Caldera Medical’s unwavering commitment to advancing women’s health and empowerment through sports and community engagement. Cynisca Cycling, an elite women's professional cycling team, is dedicated to elevating female athletes and promoting gender equality in sports. The collaboration with Caldera Medical, renowned

LOS ANGELES--(BUSINESS WIRE)--United Aesthetics Alliance (“UAA” or “the Company”), a leading provider of integrated cosmetic plastic surgery and non-invasive medical spa services sponsored by Varsity Healthcare Partners, announced it has appointed Thomas Thill as Chief Executive Officer and Benjamin Herbert as Chief Development Officer to lead the Company’s go-forward growth strategy. Mr. Thill is a seasoned healthcare leader who joins UAA with almost three decades of experience working with he